Your browser doesn't support javascript.
loading
Disease-free survival as the endpoint in multimodal rectal cancer trials: have we got this right?
Fokas, Emmanouil; Rödel, Claus; Smith, J Joshua; Garcia-Aguilar, Julio; Buyse, Marc; Glynne-Jones, Robert.
Affiliation
  • Fokas E; Department of Radiotherapy of Oncology, University of Frankfurt, Frankfurt 60590, Germany; German Cancer Research Center, Frankfurt, Germany; Frankfurt Cancer Institute, Frankfurt, Germany. Electronic address: emmanouil.fokas@kgu.de.
  • Rödel C; Department of Radiotherapy of Oncology, University of Frankfurt, Frankfurt 60590, Germany; German Cancer Research Center, Frankfurt, Germany; Frankfurt Cancer Institute, Frankfurt, Germany.
  • Smith JJ; Colorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Garcia-Aguilar J; Colorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Buyse M; Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Hasselt University, Diepenbeek, Belgium; International Drug Development Institute, San Francisco, CA, USA.
  • Glynne-Jones R; Department of Radiotherapy, Mount Vernon Centre for Cancer Treatment, Northwood, Middlesex, UK.
Lancet Gastroenterol Hepatol ; 8(11): 962-964, 2023 Nov.
Article in En | MEDLINE | ID: mdl-37625428
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Lancet Gastroenterol Hepatol Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Lancet Gastroenterol Hepatol Year: 2023 Document type: Article